Projects per year
Fingerprint
Dive into the research topics where Roxana S Dronca is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Establishment of an Inclusive Cancer Care Research Equity (iCCaRE) for Black Men Consortium
Dronca, R. S. (PI)
Congressionally Directed Medical Research Programs
1/1/21 → …
Project: Research project
-
Role of Bim and soluble B7-H1 in monitoring T cell responses to anti-PD-1 therapy in melanoma
Dong, H. M. (PI) & Dronca, R. S. (CoPI)
8/17/15 → 7/31/16
Project: Research project
-
A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis
Mosalem, O., Tan, W., Bryce, A. H., Dronca, R. S., Childs, D. S., Pagliaro, L. C., Orme, J. J. & Kase, A. M., Mar 2025, In: Prostate Cancer and Prostatic Diseases. 28, 1, p. 138-144 7 p., 34.Research output: Contribution to journal › Article › peer-review
Open Access -
Melanoma: Cutaneous, Version 2.2024 Featured Updates to the NCCN Guidelines
Swetter, S. M., Johnson, D., Albertini, M. R., Barker, C. A., Bateni, S., Baumgartner, J., Bhatia, S., Bichakjian, C., Boland, G., Chandra, S., Chmielowski, B., DiMaio, D., Dronca, R., Fields, R. C., Fleming, M. D., Galan, A., Guild, S., Hyngstrom, J., Karakousis, G. & Kendra, K. & 18 others, , Jul 1 2024, In: JNCCN Journal of the National Comprehensive Cancer Network. 22, 5, p. 290-298 9 p.Research output: Contribution to journal › Article › peer-review
-
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial
Hieken, T. J., Nelson, G. D., Flotte, T. J., Grewal, E. P., Chen, J., McWilliams, R. R., Kottschade, L. A., Yang, L., Domingo-Musibay, E., Dronca, R. S., Yan, Y., Markovic, S. N., Dimou, A., Montane, H. N., Erskine, C. L., Piltin, M. A., Price, D. L., Khariwala, S. S., Hui, J. & Strand, C. A. & 4 others, , Dec 2024, In: Nature communications. 15, 1, 1430.Research output: Contribution to journal › Article › peer-review
Open Access -
Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting
Stoff, R., Markovic, S. N., Mcwilliams, R. R., Kottschade, L. A., Montane, H. N., Dimou, A., Dudek, A. Z., Tan, W., Dronca, R. S., Seetharam, M., Chen, R. & Block, M. S., Dec 1 2024, In: Melanoma research. 34, 6, p. 510-518 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Solid cancer-directed CAR T cell therapy that attacks both tumor and immunosuppressive cells via targeting PD-L1
Luo, Y., Gadd, M. E., Qie, Y., Otamendi-Lopez, A., Sanchez-Garavito, J. E., Brooks, M. M., Ulloa Navas, M. J., Hundal, T., Li, S., Jones, V. K., Lou, Y., Patel, T., Dronca, R., Kharfan-Dabaja, M. A., Dong, H., Quinones-Hinojosa, A. & Qin, H., Dec 19 2024, In: Molecular Therapy Oncology. 32, 4, 200891.Research output: Contribution to journal › Article › peer-review
Open Access